What is ranitidine ?
Ranitidine is in a group of drugs called histamine-2 blockers. Ranitidine works by reducing the amount of acid your stomach produces.
Ranitidine is used to treat and prevent ulcers in the stomach and intestines. It also treats conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome. Ranitidine also treats gastroesophageal reflux disease (GERD) and other conditions in which acid backs up from the stomach into the esophagus, causing heartburn.
Ranitidine may also be used for purposes not listed in this medication guide.
Or
Ranitidine is used to treat and prevent ulcers in the stomach and intestines. It also treatsconditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome. Ranitidine also treats gastroesophageal reflux disease (GERD) and other conditions in which acid backs up from the stomach into the esophagus, causing heartburn.
Important information
Using ranitidine may increase your risk of developing pneumonia. Symptoms of pneumonia include chest pain, fever, feeling short of breath, and coughing up green or yellow mucus. Talk with your doctor about your specific risk of developing pneumonia.
Do not use this medication if you are allergic to ranitidine.
Ask a doctor or pharmacist if it is safe for you to take this medicine if you have kidney disease, liver disease, or porphyria.
Heartburn is often confused with the first symptoms of a heart attack. Seek emergency medical attention if you have chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, and a general ill feeling.
Ranitidine granules and effervescent tablets must be dissolved in water before you take them. Your doctor may recommend an antacid to help relieve pain. Carefully follow your doctor's directions about the type of antacid to use, and when to use it. Avoid drinking alcohol. It can increase the risk of damage to your stomach. It may take up to 8 weeks of using this medicine before your ulcer heals. For best results, keep using the medication as directed. Talk with your doctor if your symptoms do not improve after 6 weeks of treatment.
Before using ranitidine
Do not use this medication if you are allergic to ranitidine.
Heartburn is often confused with the first symptoms of a heart attack. Seek emergency medical attention if you have chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, and a general ill feeling.
Ask a doctor or pharmacist if it is safe for you to take ranitidine if you have:
- kidney disease;
- liver disease; or
- porphyria.
FDA pregnancy category B. Ranitidine is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Ranitidine passes into breast milk. Do not take ranitidine without telling your doctor if you are breast-feeding a baby.
How should I take ranitidine ?
Take ranitidine exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.
Your doctor may recommend an antacid to help relieve pain. Carefully follow your doctor's directions about the type of antacid to use, and when to use it.
Do not crush, chew, or break the ranitidine effervescent tablet, and do not allow it to dissolve on your tongue. The 25-milligram effervescent tablet must be dissolved in at least 1 teaspoon of water before swallowing. The150-milligram effervescent tablet should be dissolved in 6 to 8 ounces of water.
Allow the ranitidine effervescent tablet to dissolve completely in the water, and then drink the entire mixture. If you are giving this medicine to a child, you may draw the liquid mixture into a medicine dropper and empty the dropper into the child's mouth.
Ranitidine granules should be mixed with 6 to 8 ounces of water before drinking.
Measure ranitidine liquid with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.
It may take up to 8 weeks before your ulcer heals. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 6 weeks of treatment.
This medication can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using ranitidine.
Store ranitidine at room temperature away from moisture, heat, and light.
What happens if I miss a dose?
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
What happens if I overdose ?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Overdose symptoms may include lack of coordination, feeling light-headed, or fainting.
What should I avoid ?
Avoid drinking alcohol. It can increase the risk of damage to your stomach.
Usual Adult Dose for Duodenal Ulcer
Oral: 150 mg 2 times a day, or 300 mg once a day after the evening meal or at bedtime.
Parenteral: 50 mg, IV or IM, every 6 to 8 hours. Alternatively, a continuous IV infusion may be administered at a rate of 6.25 mg/hour over 24 hours.
Parenteral: 50 mg, IV or IM, every 6 to 8 hours. Alternatively, a continuous IV infusion may be administered at a rate of 6.25 mg/hour over 24 hours.
Usual Adult Dose for Dyspepsia
75 mg orally once daily (Over-the-counter) 30 to 60 minutes before meal. Dose may be increased to 75 mg twice daily. Maximum duration of therapy if self-medicating is 14 days.
Usual Adult Dose for Duodenal Ulcer Prophylaxis
150 mg orally once a day at bedtime.
Usual Adult Dose for Gastric Ulcer Maintenance
150 mg orally once a day at bedtime.
Usual Adult Dose for Erosive Esophagitis
Oral:
Initial: 150 mg 4 times a day.
Maintenance: 150 mg twice daily.
Parenteral: 50 mg, IV or IM, every 6 to 8 hours. Alternatively, a continuous IV infusion may be administered at a rate of 6.25 mg/hour over 24 hours.
Initial: 150 mg 4 times a day.
Maintenance: 150 mg twice daily.
Parenteral: 50 mg, IV or IM, every 6 to 8 hours. Alternatively, a continuous IV infusion may be administered at a rate of 6.25 mg/hour over 24 hours.
Usual Adult Dose for Stress Ulcer Prophylaxis
Parenteral: 50 mg, IV or IM, every 6 to 8 hours. Alternatively, a continuous IV infusion may be administered at a rate of 6.25 mg/hour over 24 hours. Titrate to maintain gastric pH >=4.0.
Usual Adult Dose for Gastrointestinal Hemorrhage
Parenteral: 50 mg IV loading dose, followed by 6.25 mg/hr continuous IV infusion titrated to gastric pH >7.0 for treatment.
Usual Adult Dose for Surgical Prophylaxis
Study (n=80) - Premedication in Thoracotomy to reduce GER:
150 mg orally 2 hours before surgery.
150 mg orally 2 hours before surgery.
Usual Adult Dose for Zollinger-Ellison Syndrome
Oral: 150 mg 2 times a day initially. Adjust dose to control gastric acid secretion. Doses up to 6 g per day have been used.
Parenteral: 1 mg/kg/hour administered as a continuous IV infusion to a maximum of 2.5 mg/kg/hour (infusion rates up to 220 mg/hour have been used).
Parenteral: 1 mg/kg/hour administered as a continuous IV infusion to a maximum of 2.5 mg/kg/hour (infusion rates up to 220 mg/hour have been used).
Usual Adult Dose for Pathological Hypersecretory Conditions
Oral: 150 mg 2 times a day initially. Adjust dose to control gastric acid secretion. Doses up to 6 g per day have been used.
Parenteral: 1 mg/kg/hour administered as a continuous IV infusion to a maximum of 2.5 mg/kg/hour (infusion rates up to 220 mg/hour have been used).
Parenteral: 1 mg/kg/hour administered as a continuous IV infusion to a maximum of 2.5 mg/kg/hour (infusion rates up to 220 mg/hour have been used).
Usual Adult Dose for Gastroesophageal Reflux Disease
Oral: 150 mg twice daily.
Parenteral: 50 mg, IV or IM, every 6 to 8 hours.
Parenteral: 50 mg, IV or IM, every 6 to 8 hours.
Usual Adult Dose for Gastric Ulcer
Benign Gastric Ulcer -
Oral: 150 mg twice a day.
Parenteral: 50 mg, IV or IM, every 6 to 8 hours.
Oral: 150 mg twice a day.
Parenteral: 50 mg, IV or IM, every 6 to 8 hours.
Usual Pediatric Dose for Duodenal Ulcer
1 month to 16 years:
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day IV
Oral:
Treatment: 4 to 8 mg/kg twice daily, every 12 hours
Maximum: 300 mg/day orally
Maintenance: 2 to 4 mg/kg/day orally once daily
Maximum: 150 mg/day orally
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day IV
Oral:
Treatment: 4 to 8 mg/kg twice daily, every 12 hours
Maximum: 300 mg/day orally
Maintenance: 2 to 4 mg/kg/day orally once daily
Maximum: 150 mg/day orally
Usual Pediatric Dose for Gastric Ulcer
1 month to 16 years:
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day IV
Oral:
Treatment: 4 to 8 mg/kg twice daily, every 12 hours
Maximum: 300 mg/day orally
Maintenance: 2 to 4 mg/kg/day orally once daily
Maximum: 150 mg/day orally
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day IV
Oral:
Treatment: 4 to 8 mg/kg twice daily, every 12 hours
Maximum: 300 mg/day orally
Maintenance: 2 to 4 mg/kg/day orally once daily
Maximum: 150 mg/day orally
Usual Pediatric Dose for Duodenal Ulcer Prophylaxis
1 month to 16 years:
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day
Oral: 2 to 4 mg/kg once daily, not to exceed 150 mg/24 hours.
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day
Oral: 2 to 4 mg/kg once daily, not to exceed 150 mg/24 hours.
Usual Pediatric Dose for Gastric Ulcer Maintenance
1 month to 16 years:
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day
Oral: 2 to 4 mg/kg once daily, not to exceed 150 mg/24 hours.
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day
Oral: 2 to 4 mg/kg once daily, not to exceed 150 mg/24 hours.
Usual Pediatric Dose for Gastroesophageal Reflux Disease
Neonatal:
IV: 1.5 mg/kg IV as a loading dose followed 12 hours later with 1.5 to 2 mg/kg/day IV divided every 12 hours. Alternatively, a continuous IV infusion may be administered at a rate of 0.04 to 0.08 mg/kg/hour (1 to 2 mg/kg/day) after a loading dose of 1.5 mg/kg has been given.
Continuous IV infusion: Loading dose: 1.5 mg/kg/dose, followed by 0.04 to 0.08 mg/kg/hour infusion (or 1 to 2 mg/kg/day).
Oral: 2 mg/kg/day divided into 2 doses, administered every 12 hours.
1 month to 16 years:
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day. Alternatively, an initial IV bolus dose of 1 mg/kg given once, followed by a constant IV infusion at a rate of 0.08 to 0.17 mg/kg/hour (2 to 4 mg/kg/day) may be administered.
Oral: 4 to 10 mg/kg/day administered in 2 divided doses, every 12 hours.
Maximum: 300 mg orally day
IV: 1.5 mg/kg IV as a loading dose followed 12 hours later with 1.5 to 2 mg/kg/day IV divided every 12 hours. Alternatively, a continuous IV infusion may be administered at a rate of 0.04 to 0.08 mg/kg/hour (1 to 2 mg/kg/day) after a loading dose of 1.5 mg/kg has been given.
Continuous IV infusion: Loading dose: 1.5 mg/kg/dose, followed by 0.04 to 0.08 mg/kg/hour infusion (or 1 to 2 mg/kg/day).
Oral: 2 mg/kg/day divided into 2 doses, administered every 12 hours.
1 month to 16 years:
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day. Alternatively, an initial IV bolus dose of 1 mg/kg given once, followed by a constant IV infusion at a rate of 0.08 to 0.17 mg/kg/hour (2 to 4 mg/kg/day) may be administered.
Oral: 4 to 10 mg/kg/day administered in 2 divided doses, every 12 hours.
Maximum: 300 mg orally day
Usual Pediatric Dose for Erosive Esophagitis
1 month to 16 years:
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day. Alternatively, an initial IV bolus dose of 1 mg/kg given once, followed by a constant IV infusion at a rate of 0.08 to 0.17 mg/kg/hour (2 to 4 mg/kg/day) may be administered.
Oral: 4 to 10 mg/kg/day administered in 2 divided doses, every 12 hours.
Maximum: 300 mg orally day
IV: 2 to 4 mg/kg/day divided every 6 to 8 hours
Maximum: 200 mg/day. Alternatively, an initial IV bolus dose of 1 mg/kg given once, followed by a constant IV infusion at a rate of 0.08 to 0.17 mg/kg/hour (2 to 4 mg/kg/day) may be administered.
Oral: 4 to 10 mg/kg/day administered in 2 divided doses, every 12 hours.
Maximum: 300 mg orally day
Usual Pediatric Dose for Dyspepsia
Children greater than or equal to 12 years:
75 mg orally once 30 to 60 minutes before eating food or drinking beverages which cause heartburn.
Maximum: 150 mg/24 hours
Duration of therapy: Do not use for more than 14 days
75 mg orally once 30 to 60 minutes before eating food or drinking beverages which cause heartburn.
Maximum: 150 mg/24 hours
Duration of therapy: Do not use for more than 14 days
Renal Dose Adjustments
CrCl less than 50 mL/min:
Oral: 150 mg every 24 hours. Dosing may be increased further with caution.
IV: 50 mg every 18 to 24 hours IV or by continuous IV infusion. Dosing may be increased further with caution.
Monitoring of renal function is recommended.
Oral: 150 mg every 24 hours. Dosing may be increased further with caution.
IV: 50 mg every 18 to 24 hours IV or by continuous IV infusion. Dosing may be increased further with caution.
Monitoring of renal function is recommended.
Liver Dose Adjustments
Data not available
Dose Adjustments
Ranitidine injection may be used in some hospitalized patients with pathological hypersecretory conditions or intractable duodenal ulcers, or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication. Generally, the dosage should not exceed 400 mg/day.
Short-term treatment of active duodenal ulcer: most patients heal within 4 weeks. There are no data on the use of ranitidine in uncomplicated duodenal ulcer for periods longer than 8 weeks.
Short-term treatment of active, benign gastric ulcer: most patients heal within 6 weeks. There are no data on the use of ranitidine in uncomplicated benign gastric ulcer for periods longer than 6 weeks.
Maintenance therapy for gastric and duodenal ulcer at reduced dosage after healing of acute ulcers: There are no data on the use of ranitidine for longer than 1 year.
Maintenance of healing of erosive esophagitis: There are no data for the use of ranitidine beyond 48 weeks.
Short-term treatment of active duodenal ulcer: most patients heal within 4 weeks. There are no data on the use of ranitidine in uncomplicated duodenal ulcer for periods longer than 8 weeks.
Short-term treatment of active, benign gastric ulcer: most patients heal within 6 weeks. There are no data on the use of ranitidine in uncomplicated benign gastric ulcer for periods longer than 6 weeks.
Maintenance therapy for gastric and duodenal ulcer at reduced dosage after healing of acute ulcers: There are no data on the use of ranitidine for longer than 1 year.
Maintenance of healing of erosive esophagitis: There are no data for the use of ranitidine beyond 48 weeks.
Precautions
Symptomatic response to ranitidine does not rule out the possibility of gastrointestinal malignancy.
Dosage adjustments are recommended in patients with creatinine clearance less than 50 mL/min, and periodic monitoring of renal function is recommended.
Caution should be exercised when administering ranitidine to patients with hepatic dysfunction since ranitidine is metabolized in the liver.
Ranitidine should be avoided in patients with a history of acute porphyria because of rare reports that suggest that ranitidine may precipitate acute porphyric attacks in patients with acute porphyria.
Caution should be exercised when administering ranitidine intravenously to patients with contributing factors predisposing them to cardiac rhythm disturbances. Bradycardia has been reported in association with rapid intravenous administration of ranitidine.
Elevations in SGPT have been reported with the administration of intravenous H2 antagonists, for 5 days or longer, at doses larger than recommended.
Ranitidine may produce false-positive tests results for urine protein with Multistix (R). Testing with sulfosalicylic acid is recommended.
The efferdose tablets should not be chewed, swallowed whole, or dissolved on the tongue. These tablets contain phenylalanine.
Agents in this class of drugs (H2 antagonists) have not demonstrated unequivocal efficacy in the treatment of upper gastrointestinal hemorrhage, nor are they approved by the FDA for use in this setting. However, some clinicians use intravenous H2 antagonists as part of the therapeutic approach to treating upper gastrointestinal hemorrhage.
Safety and efficacy in pediatric patients for the treatment of pathological hypersecretory conditions or the maintenance of healing of erosive esophagitis have not been established. Safety and efficacy in neonates (less than 1 month of age) have not been determined.
Dosage adjustments are recommended in patients with creatinine clearance less than 50 mL/min, and periodic monitoring of renal function is recommended.
Caution should be exercised when administering ranitidine to patients with hepatic dysfunction since ranitidine is metabolized in the liver.
Ranitidine should be avoided in patients with a history of acute porphyria because of rare reports that suggest that ranitidine may precipitate acute porphyric attacks in patients with acute porphyria.
Caution should be exercised when administering ranitidine intravenously to patients with contributing factors predisposing them to cardiac rhythm disturbances. Bradycardia has been reported in association with rapid intravenous administration of ranitidine.
Elevations in SGPT have been reported with the administration of intravenous H2 antagonists, for 5 days or longer, at doses larger than recommended.
Ranitidine may produce false-positive tests results for urine protein with Multistix (R). Testing with sulfosalicylic acid is recommended.
The efferdose tablets should not be chewed, swallowed whole, or dissolved on the tongue. These tablets contain phenylalanine.
Agents in this class of drugs (H2 antagonists) have not demonstrated unequivocal efficacy in the treatment of upper gastrointestinal hemorrhage, nor are they approved by the FDA for use in this setting. However, some clinicians use intravenous H2 antagonists as part of the therapeutic approach to treating upper gastrointestinal hemorrhage.
Safety and efficacy in pediatric patients for the treatment of pathological hypersecretory conditions or the maintenance of healing of erosive esophagitis have not been established. Safety and efficacy in neonates (less than 1 month of age) have not been determined.
Dialysis
Hemodialysis reduces the level of ranitidine. Doses should be administered at the end of hemodialysis session.
Other Comments
Agents in this class of drugs (H2 antagonists) have not demonstrated unequivocal efficacy in the treatment of upper gastrointestinal hemorrhage, nor are they approved by the FDA for use in this setting. However, some clinicians use intravenous H2 antagonists as part of the therapeutic approach to treating upper gastrointestinal hemorrhage.
Ranitidine side effects
Stop using ranitidine and get emergency medical help if you have any of these signs of an allergic reaction to ranitidine: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop taking ranitidine and call your doctor at once if you have a serious side effect such as:
- chest pain, fever, feeling short of breath, coughing up green or yellow mucus;
- easy bruising or bleeding, unusual weakness;
- fast or slow heart rate;
- problems with your vision;
- fever, sore throat, and headache with a severe blistering, peeling, and red skin rash; or
- nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Less serious ranitidine side effects may include:
- headache (may be severe);
- drowsiness, dizziness;
- sleep problems (insomnia);
- decreased sex drive, impotence, or difficulty having an orgasm; or
- swollen or tender breasts (in men);
- nausea, vomiting, stomach pain; or
- diarrhea or constipation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
What other drugs will affect ranitidine ?
Before taking ranitidine, tell your doctor if you are taking triazolam (Halcion). You may not be able to use ranitidine, or you may need dosage adjustments or special tests during treatment.
There may be other drugs that can interact with ranitidine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
What is the most important information I should know about Ranitidine?
Heartburn is often confused with the first symptoms of a heart attack. Seek emergency medical attention if you have chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, and a general ill feeling.
Do not use this medication if you are allergic to ranitidine.
Ask a doctor or pharmacist if it is safe for you to take this medicine if you have kidney disease, liver disease, or porphyria.
Using ranitidine may increase your risk of developing pneumonia. Symptoms of pneumonia include chest pain, fever, feeling short of breath, and coughing up green or yellow mucus. Talk with your doctor about your specific risk of developing pneumonia.
Ranitidine granules and effervescent tablets must be dissolved in water before you take them.
Your doctor may recommend an antacid to help relieve pain. Carefully follow your doctor's directions about the type of antacid to use, and when to use it.
Avoid drinking alcohol. It can increase the risk of damage to your stomach.
It may take up to 8 weeks of using this medicine before your ulcer heals. For best results, keep using the medication as directed. Talk with your doctor if your symptoms do not improve after 6 weeks of treatment.
What should I discuss with my healthcare provider before taking Ranitidine?
Heartburn is often confused with the first symptoms of a heart attack. Seek emergency medical attention if you have chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, and a general ill feeling.
Do not use this medication if you are allergic to ranitidine.
Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:
FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
Ranitidine passes into breast milk. Do not take ranitidine without telling your doctor if you are breast-feeding a baby.
Using ranitidine may increase your risk of developing pneumonia. Symptoms of pneumonia include chest pain, fever, feeling short of breath, and coughing up green or yellow mucus. Talk with your doctor about your specific risk of developing pneumonia.
The ranitidine effervescent tablet may contain phenylalanine. Talk to your doctor before using this form of ranitidine if you have phenylketonuria (PKU).
Ranitidine Dosage
How should I take Ranitidine?
Take exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.
Your doctor may recommend an antacid to help relieve pain. Carefully follow your doctor's directions about the type of antacid to use, and when to use it.
Do not crush, chew, or break the ranitidine effervescent tablet, and do not allow it to dissolve on your tongue. The 25-milligram effervescent tablet must be dissolved in at least 1 teaspoon of water before swallowing. The150-milligram effervescent tablet should be dissolved in 6 to 8 ounces of water.
Allow the ranitidine effervescent tablet to dissolve completely in the water, and then drink the entire mixture. If you are giving this medicine to a child, you may draw the liquid mixture into a medicine dropper and empty the dropper into the child's mouth.
Ranitidine granules should be mixed with 6 to 8 ounces of water before drinking.
Measure ranitidine liquid with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.
It may take up to 8 weeks before your ulcer heals. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 6 weeks of treatment.
This medication can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using ranitidine.
Store at room temperature away from moisture, heat, and light.
What happens if I overdose on Ranitidine?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Overdose symptoms may include lack of coordination, feeling light-headed, or fainting.
What happens if I miss a dose of Ranitidine?
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
| Brand Name | Contains | Dosage Form | Manufacturer | Price(Tk.) |
| G-RANITIDINE | Ranitidine 150mg/tablet | Tablet | Gonoshasthya Pharmaceuticals Ltd. | 100s pack: 142.00 MRP |
| GASTROLOC | Ranitidine 150mg/tablet | Tablet | BeaconPharmaceuticals Ltd | 100s pack: 200.00 MRP |
| GEPIN | Ranitidine 150mg/tablet | Tablet | General Pharmaceuticals Ltd. | 100s pack: 200.00 MRP |
| GEPIN | Ranitidine 75mg/5ml | Syrup | General Pharmaceuticals Ltd. | 100ml bot: 40.00 MRP 200ml bot: 70.00 MRP |
| H2-150 | Ranitidine 150mg/tablet | Tablet | ApolloPharmaceutical Laboratories Ltd. | 100s pack: 200.00 IP |
| HI-TAC | Ranitidine 150mg/tablet | Tablet | Hudson Pharmaceutical Ltd. | 100s pack: 150.00 MRP |
| INRAN 150 | Ranitidine 150mg/tablet | Tablet | Monico Pharmaceuticals Ltd. | 100s pack: 200.00 MRP |
| INSEAC | Ranitidine 150mg & 300mg/tablet | Tablet | Ibn Sina Pharmaceutical Ind. Ltd. | 150mg x 100s pack: 200.00 IP 300mg x 48s pack: 184.32 IP |
| JOVRAN | Ranitidine 150mg/tablet | Tablet | Belsen Pharmaceuticals Ltd. | 150mg x 100s pack: 200.00 MRP |
| LIBRET I.V | Ranitidine Hydrochloride 50mg in 100ml(0.5mg/ml) | I.V Infusion | Libra Pharmaceuticals Ltd. | 100ml bot:55.00 MRP |
| LUMERAN | Ranitidine 150mg/tablet | Tablet | Aristopharma Ltd. | 150mg x 100s pack: 215.00 IP |
| MUTAC-150 | Ranitidine 150mg/tablet | Tablet | Salton Pharmaceuticals Ltd. | 150mg x 100s pack: 200.00 MRP |
| MYSTIN-R | Ranitidine 150mg/tablet | Tablet | Mystic Pharmaceuticals Ltd. | 150mg x 100s pack: 200.00 |
| NEOCEPTIN-R | Ranitidine 150mg and 300 mg/tablet | Tablet | Beximco Pharmaceuticals Ltd. | 150mg x 150s pack: 375.00 MRP 300mg x 100s pack: 400.00 MRP |
| NEOCEPTIN-R | Ranitidine 75mg/5ml | Syrup | Beximco Pharmaceuticals Ltd. | 100ml bot : 45.00 MRP |
| NEOCEPTIN-R | Ranitidine Hydrochloride 50mg in 100ml(0.5mg/ml) | I.V Infusion | Beximco Pharmaceuticals Ltd. | 100ml bottle:101.00 MRP |
| NEODIN-R | Ranitidine 150mg/tablet | Tablet | Skylab Ltd. | 150mg x 100s pack: 205.00 MRP |
| NEOPEP | Ranitidine 150mg/tablet | Tablet | Central Pharmaceuticals Ltd. | 150mg x 100s pack: 150.00 MRP |
| NEOSETIN R-150 | Ranitidine 150mg/tablet | Tablet | Bristol Pharma Ltd. | 50mg x 100s pack: 150.00 MRP |
| NEOTACK | Ranitidine 150mg & 300mg/tablet | Tablet | Square Pharmaceutical Ltd. | 150mg x 150s pack: 300.00 MRP 300mg x 100s pack: 400.00 MRP |
| Brand Name | Contains | Dosage Form | Manufacturer | Price(Tk.) |
| ACEPTIN-R | Ranitidine 150mg/tablet | Tablet | Asiatic Laboratories Ltd. | 100s pack: 200.00 MRP |
| ACIN | Ranitidine 150mg&300mg/table | Tablet | Bio PharmaLaboratories Ltd. | 150mg x 100s pack: 200.00 MRP 300mg x 50s pack: 175.00 MRP |
| ACIN | Ranitidine 75mg/5ml | Syrup | Bio Pharma Laboratories Ltd. | 100ml bot: 45.00 MRP |
| ALIN | Ranitidine 150mg/tablet | Tablet | Rephco Laboratories Ltd. | 100s pack: 200.00 MRP |
| ANTAC | Ranitidine 150mg/tablet | Tablet | Ambee Pharmaceuticals Ltd. | 100s pack: 180.00 MRP |
| ANTAC | Ranitidine 75mg/5ml | Syrup | Ambee Pharmaceuticals Ltd. | 100ml bot: 40.00 MRP |
| ANTAC | Ranitidine 50mg/2ml ampoule | Injection | Ambee Pharmaceuticals Ltd. | 10 amps pack: 53.00 MRP |
| ASINAR | Ranitidine 150mg/tablet | Tablet | Sanofi-aventisBangladesh Ltd. | 150mg x 100s pack: 200.00 MRP |
| BENTID | Ranitidine 150mg/tablet | Tablet | Benham Pharmaceuticals Ltd. | 100s pack: 141.00 IP |
| DENITINE | Ranitidine 150mg/tablet | Tablet | Doctor's Chemicals Works Ltd. | 100s pack: 200.00 MRP |
| DETAC | Ranitidine 75mg/5ml | Syrup | Desh Pharmaceuticals [Pvt] Ltd. | 100ml bot: 40.00 MRP |
| DETAC-150 | Ranitidine 150mg/tablet | Tablet | Desh Pharmaceuticals [Pvt] Ltd. | 150s pack: 225.00 MRP |
| DUGAL | Ranitidine 150mg & 300mg/tablet | Tablet | Reman Drug Laboratories Ltd. | 150mg x 100s pack: 115.00 MRP 300mg x 50s pack: 200.00 MRP |
| DURAN | Ranitidine 150mg & 300mg/tablet | Tablet | Techno Drugs | 150mg x 100s pack: 200.00 MRP 300mg x 100s pack: 400.00 MRP |
| DURAN | Ranitidine 75mg/5ml | Syrup | Techno Drugs | 100ml bot: 40.00 MRP |
| DURAN | Ranitidine hydrochloride 50mg in 100ml (0.5mg/ml) bottle | I.V Infusion | Techno Drugs | 100ml bot :60.00 MRP |
| EDITIN-R | Ranitidine 150mg/Tablet | Tablet | Edruc Ltd. | 100s pack: 223.00 IP |
| EDITIN-R | Ranindine 50mg/2ml ampoule | Injection | Edruc Ltd. | 10 amps pack: 60.00 IP |
| EUCON | Ranitidine 150mg/tablet | Tablet | Pacific Pharmaceuticals Ltd. | 100s pack: 190.00 MRP |
| EXAC | Ranitidine 150mg/tablet | Tablet | Hallmark Pharmaceuticals Ltd. | 100s pack: 150.00 MRP |
| Brand Name | Contains | Dosage Form | Manufacturer | Price(Tk.) |
| NEOTACK | Ranitidine 75mg/5ml | Syrup | Square Pharmaceutical Ltd. | 100ml bot: 45.00 MRP |
| NEOTACK | Ranitidine 50mg/2ml ampoule | Injection | Square Pharmaceutical Ltd. | 10 amps pack:60.00 MRP |
| NEOTID | Ranitidine 150mg/tablet | Tablet | Modern Pharmaceuticals Ltd. | 150mg x 100s pack: 200.00 MRP |
| NEOTIN | Ranitidine 150mg/tablet | Tablet | Nipa Pharmaceuticals Ltd. | 150mg x 100s pack: 200.00 MRP |
| NORMA-H | Ranitidine 150mg/tablet | Tablet | Renata Ltd. | 150mg x 100s pack: 218.00 MRP |
| NORMACID | Ranitidine 150mg/tablet | Tablet | Kemiko Pharmaceuticals Ltd. | 150mg x 100s pack: 200.00 MRP |
| NORMACID | Ranitidine 75mg/5ml | Syrup | Kemiko Pharmaceuticals Ltd. | 100ml bot: 40.00 MRP |
| ORTAC | Ranitidine 150mg/tablet | Tablet | Orion Laboratories Ltd. | 150mg x 100s pack: 200.00 MRP |
| ORTAC I.V | Ranitidine hydrochloride 50mg in 100ml (0.5mg/ml ) | I.V Infusion | Orion Infusion Ltd. | 100ml bot: 60.00 MRP |
| PEOTID | Ranitidine 150mg/tablet | Tablet | Peoples Pharma Ltd. | 150mg x 100s pack: 210.00 MRP |
| PEPTIDIN-150 | Ranitidine 150mg/tablet | Tablet | Cosmic Chemical Industries Ltd. | 100s pack: 150.00 MRP |
| PEPTIL-H | Ranitidine 150mg/tablet | Tablet | Eskayef Bangladesh Ltd. | 150mg x 100s pack: 200.00 MRP |
| PEPTIL-H | Ranitidine 75mg/5ml | Syrup | Eskayef Bangladesh Ltd. | 100ml bot: 45.00 MRP |
| PEPTONIL | Ranitidine 150mg/tablet | Tablet | Decent Pharma Laboratories Ltd. | 100s pack: 200.00 MRP |
| PEPTOSOL | Ranitidine hydrochloride 50mg in 100ml (0.5mg/ml) bottle, premixed in 0.45% sodium chloride solution | I.V Infusion | Opso Saline Ltd. | 100ml bot: 35.00 MRP |
| PROTEC-R | Ranitidine 150mg/tablet | Tablet | Globex Pharmaceuticals Ltd. | 100s pack: 200.00 MRP |
| RANBEX | Ranitidine 150mg/tablet | Tablet | NOVO Healthcare & Pharma Ltd. | 100s pack: 200.00 MRP |
| RANI | Ranitidine 150mg/tablet | Tablet | Cosmo Pharma Laboratories Ltd. | 100s pack: 202.00 MRP |
| RANI-150 | Ranitidine 150mg/tablet | Tablet | ALCO Pharma Ltd. | 100s pack: 200.00 MRP |
| RANID | Ranitidine 150mg/tablet | Tablet | Ziska Pharmaceuticals Ltd. | 100s pack: 110.00 MRP |
| Brand Name | Contains | Dosage Form | Manufacturer | Price(Tk.) |
| RANID | Ranitidine 50mg/2ml ampoule | Injection | Ziska Pharmaceuticals Ltd. | 10 amps pack: 60.00 MRP |
| RANIDIL | Ranitidine 150mg/tablet | Tablet | Millat Pharmaceuticals Ltd. | 100s pack: 200.00 MRP |
| RANIDIN | Ranitidine 150mg & 300mg/tablet | Tablet | ACME Laboratories Ltd. | 150mg x 100s pack: 200.00 MRP 300mg x 100s pack: 400.00 MRP |
| RANIDIN | Ranitidine 50mg/2ml ampoule | Injection | ACME Laboratories Ltd. | 10 amps pack: 60.00 MRP |
| RANILOC | Ranitidine 150mg/tablet | Tablet | Kumudini PharmaLtd. | 150s pack: 225.00 MRP |
| RANISON | Ranitidine 150mg/tablet | Tablet | Jayson Pharmaceuticals Ltd. | 100s pack: 171.00 IP |
| RANISON | Ranitidine 50mg/2ml | Injection | Jayson Pharmaceuticals Ltd. | 10 amps pack: 62.80 IP |
| RANISYN | Ranitidine 150mg/tablet | Tablet | Syntho Laboratories Ltd. | 100s pack: 210.00 MRP |
| RANIT | Ranitidine 150mg & 300mg /tablet | Tablet | Pharmadesh Laboratories Ltd. | 300mg x 50s pack: 150.00 MRP 150mg x 100s pack:120.00 MRP |
| RANITAB | Ranitidine 150mg/tablet | Tablet | Sonear Laboratories Ltd. | 100s pack: 200.00 MRP |
| RANITACK | Ranitidine 150mg/tablet | Tablet | Ad-Din Pharmaceuticals Ltd. | 100s pack: 75.00 MRP |
| RANITEC-150 | Ranitidine 150mg/tablet | Tablet | APC Pharmaceuticals Ltd. | 100s pack: 200.00 MRP |
| RANITID | Ranitidine 150mg/tablet | Tablet | Opsonin Pharma Ltd. | 150mg x 100s pack: 300.00 MRP |
| RANITID | Ranitidine 75mg/5ml | Syrup | Opsonin Pharma Ltd. | 100ml bot: 45.00 MRP |
| RANITID | Ranitidine 50mg/2ml ampoule | Injection | Opsonin Pharma Ltd. | 50 amps pack: 300.00 MRP |
| RANITOR | Ranitidine 150mg/tablet | Tablet | Popular Pharmaceuticals Ltd. | 100s pack: 100.00 IP |
| RANIX | Ranitidine 150mg/tablet | Tablet | Chemist Laboratories Ltd. | 100s pack: 75.00 MRP |
| RANIX | Ranitidine 50mg/2ml ampoule | Injection | Chemist Laboratories Ltd. | 10 amps pack: 50.00 MRP |
| RANTEC | Ranitidine 150mg & 300mg/tablet | Tablet | Medimet Pharmaceuticals Ltd. | 150mg x 100s pack: 200.00 MRP 300mg x 50s pack: 175.00 MRP |
| RANTIN | Ranitidine 150mg/tablet | Tablet | Seema Pharmaceuticals Ltd. | 100s pack: 210.00 MRP |
| Brand Name | Contains | Dosage Form | Manufacturer | Price(Tk.) |
| RANUL | Ranitidine 150mg/tablet | Tablet | Apex PharmaLtd. | 100s pack: 100.00 MRP |
| RAVIA | Ranitidine 150mg/tablet | Tablet | Pharmasia Ltd. | 100s pack: 100.00 IP |
| REETAC-R | Ranitidine 150mg & 300mg/tablet | Tablet | Navana Pharmaceuticals Ltd. | 150mg x 100s pack: 200.00 MRP 300mg x 50s pack: 200.00 MRP |
| RENICON | Ranitidine 150mg/tablet | Tablet | Medicon Laboratories Ltd. | 100s pack: 150.00 MRP |
| RHINE | Ranitidine 150mg/tablet | Tablet | HealthcarePharmaceuticals Ltd. | 60s pack: 150.00 IP |
| ROSTID | Ranitidine 150mg/tablet | Tablet | Rasa Pharmaceuticals Ltd. | 100s pack: 155.00 MRP |
| RT 150 | Ranitidine 150mg/tablet | Tablet | Silva Pharmaceuticals Ltd. | 100s pack: 200.00 MRP |
| SADIN | Ranitidine 150mg/table | Tablet | Shamsul Alamin Pharmaceuticals Ltd. | 100s pack: 150.00 MRP |
| SUTAC | Ranitidine 150mg/tablet | Tablet | Supreme Pharmaceuticals Ltd. | 100s pack: 200.00 MRP |
| TINADIN | Ranitidine 150mg/tablet | Tablet | Delta Pharma Ltd. | 100s pack: 85.00 MRP |
| TINADIN | Ranitidine 75mg/5ml | Syrup | Delta Pharma Ltd. | 100ml bot: 40.00 MRP |
| TYTAC | Ranitidine 150mg/tablet | Tablet | Proteety Pharmaceuticals Ltd. | 100s pack: 150.00 MRP |
| ULCAR | Ranitidine 150mg & 300mg/tablet | Tablet | Drug International Ltd. | 150mg x 100s pack: 200.00 MRP 300mg x 50s pack: 200.00 MRP |
| ULCITID | Ranitidine 150mg/tablet | Tablet | Marksman Pharmaceuticals Ltd. | 100s pack: 200.00 MRP |
http://www.bddrugs.com/product5.php?page=5&idn=3&prev1=&prev
http://www.everydayhealth.com/drugs/ranitidine#side-effects
0 comments:
Post a Comment